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Endocarditis is a life-threatening disease with high mortality and morbidity. In clinical practice, we try 
to improve the outcome of patients with endocarditis by implementing a better and faster diagnostic 
workup, a timely start of antimicrobial therapy and an early surgical intervention if required. In the most 
recent update of the guidelines for the management of patients with endocarditis, an Endocarditis Team 
is put forward as crucial part in the improvement of care for patients with (suspected) endocarditis. 
They state that endocarditis requires a multidisciplinary approach since patients present with highly 
variable signs and symptoms, need a high-standard of care from several medical specialists, and need 
to be discussed in a surgical team early in the course of the disease. Observational studies support this 
implementation by showing a marked decrease in mortality after discussing endocarditis patients in an 
Endocarditis Team. This article discusses the experience with the implementation of an Endocarditis 
Team in two different regions of the Netherlands (Rotterdam-Rijnmond and Groningen). Which aspects 
are important for the structure and function of an Endocarditis Team? Setting up of an Endocarditis Team 
can be difficult, therefore we provide some practical advice. Finally, an illustrative case is presented.
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Introduction
Endocarditis is a severe disease with high mortality and morbidity. Published mortality rates are in the 
in-hospital and active phase of disease 14-22% and 40% after one year (even 25-59% for prosthetic 
valve endocarditis).1,2 The high morbidity results from local cardiac destruction and bodily infarcts due 
to embolism formation. The incidence of endocarditis did not decline as a result of a change in risk 
factors.3 In countries with high incomes, the risk factors of degenerative heart disease, congenital heart 
disease, intravenous drug use, diabetes mellitus, cancer and heart failure became more common; 
intracardiac prosthetic material is also implanted more often (prosthetic valve, pacemaker/implantable 
cardioverter defibrillator, patches) and the population aged.2,3 In clinical practice, we try to improve 
the care for these patients through prompt and adequate diagnosing and early start with adequate 
antimicrobial therapy combined with surgical therapy if indicated. Therefore, it is essential to identify 
the pathogen and its antimicrobial resistance pattern if possible, including the minimum inhibitory 
concentration (MIC) of the pathogen for different antibiotic agents.
For the diagnosis of infective endocarditis, important support is provided by the modified Duke criteria4, 
supplemented with the guidelines of the European Society of Cardiology (ESC)5 and the American Heart 
Association (AHA).6,7 In these recent guidelines a number of critical adaptations are introduced. For the 
first time “the Endocarditis Team” is presented as critical part in the care for patients with (a suspicion 
of) endocarditis.5-8 In addition, a prominent place is given to non-invasive imaging techniques as addition 
to echocardiography, namely F-18 fluorodeoxyglucose positron emission tomography with low-dose 
computed tomography (FDG-PET/CT), cardiac CT, and single-photon emission computed tomography 
(SPECT)/CT with radiolabeled leukocytes.5
The Endocarditis Team
The European guidelines on endocarditis (ESC)5 state that endocarditis should be managed by a 
multidisciplinary team as: 1) it is a complex disease, presenting with highly variable signs and symptoms 
depending on the first involved organs, the underlying heart disease, the pathogen, the resulting 
complications and the characteristics of the patient; 2) expertise is needed from several medical 
specialties (including cardiology, cardiothoracic surgery, internal medicine/infectious diseases, medical 
microbiology); 3) an important proportion of patients has an indication to undergo surgery during 
hospital admission and therefore it is important to discuss patients early in their course of disease in a 
surgical team.9 
For a true clinical impact of an Endocarditis Team, it is important to critically evaluate all clinical and 
diagnostic data during a meeting with all medical specialists present in order to develop and evaluate 
an individual plan for each patient. The modified Duke criteria provide a basic structure to come to a 
diagnosis of endocarditis (sensitivity and specificity of approximately 80% for native valves4 and an even 
lower sensitivity and specificity in case of missing information and/or intracardiac prosthetic material in 
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situ). However, clinical reasoning by experts in the individual context of the patient is critical to come to 
the final diagnosis.2 A point of caution is the way that missing information is handled in this regard (for 
example diagnostic tests that are not at all or not completely available, e.g. one set of blood cultures 
before starting antimicrobial therapy, only).
Two European observational studies indeed showed that the outcome of patients with endocarditis 
is improved after discussing them in an Endocarditis Team. A French observational study included 
333 patients with definite endocarditis according to the modified Duke criteria, including 
streptococci, enterococci, staphylococci and micro-organisms of the HACEK-group as pathogens.10 A 
significant reduction from 18.5% to 8.2% was reported in the one-year mortality after introduction 
of a multidisciplinary Endocarditis Team.10 An Italian observational study included 292 patients with 
definite native valve endocarditis according to the modified Duke criteria.11 In this study, a formalized, 
multidisciplinary and coordinated workup was introduced stating that patients needed to be evaluated 
within 12 hours after hospital admission, early surgery of patients with an indication (within 48 hours 
if needed) and weekly evaluation of stable patients. A significant reduction was reported of in-hospital 
mortality (from 28% to 13%), of surgery-related mortality during the active phase of disease (from 47% 
to 13%), and of three-year mortality (from 34% to 16%). Based on these two studies, the American 
guideline for the management of patients with valve disease (AHA/ACC) recommended to have an 
Endocarditis Team in reference centers (class IB).7
Setting up an Endocarditis Team in your center
The Endocarditis Team should operate in consultation with all regional medical specialties involved in 
the care for patients with infective endocarditis. This type of specialized patient care should ultimately 
be centralized in order to increase the required experience and expertise. This centralization can 
physically be best situated in an academic hospital or top clinical center concerning logistical reasons. 
It is advised to set up “satellite Endocarditis Team” in all referring centers, as to optimize the diagnostic 
workup and therapy as early as possible and before the planned care is discussed with the Endocarditis 
Team in the referral center.
Where to start with the setting up of an Endocarditis Team? The European guideline5 provides some 
support by giving answers for questions such as: 1) When to refer a patient with endocarditis to the 
Endocarditis Team in a referral center? 2) Which expertise is demanded in a referral center? 3) Which 
composition and role should an Endocarditis Team have? This article discusses these three questions 
in the guideline5 (originally in Dutch), supported by providing our concept of, and experience with, 
setting up of an Endocarditis Team in our regions. Which aspects are important for the structure and 
function of an Endocarditis Team? We experienced that setting up of an Endocarditis Team can be 
difficult. Therefore, we provide some additional practical tips. At the end of this article, we describe an 
illustrative case (Figure 2a) to highlight the function and added value of the Endocarditis Team.
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The structure and function of an Endocarditis Team
Tasks of the Endocarditis Team5
- Central role in diagnostics and therapy for patients with (a suspicion of) endocarditis, 
including bed-side consultation by an internist/infectious disease (ID) specialist, antimicrobial/
diagnostic stewardship, referral and follow-up.
- Improvement of the quality of medical care for patients with endocarditis (cycle for quality 
improvement).
- Participation in local, national and international patient registries, with publication of 
mortality and morbidity in the medical center.
- Patient education programs.
Characteristics of a referral center5
- Easy access to cardiothoracic surgery.
- Direct access to diagnostics: transthoracic (TTE) and transesophageal (TEE) echocardiography, 
diagnostic CT for the heart, MRI and nuclear imaging (18F-FDG PET/CT, possibly SPECT/CT with 
radiolabeled leukocytes).
- Endocarditis Team is physically present.
Composition of an Endocarditis Team5
Several medical specialties form the core of the team. This core team can be expanded if needed:
- Core team: cardiologists with expertise in echocardiography and valvular heart disease, 
cardiothoracic surgeons with expertise in the field of valve surgery and endocarditis, internist/
ID specialists, medical microbiologists, radiologists and nuclear physicians with specific 
expertise in the field of endocarditis.
- Expansion, indicated per patient: cardiologists with expertise in pacemakers / implantable 
cardioverter defibrillators or congenital heart disease, intervention cardiologists, 
neurologists, orthopedics, hospital pharmacists with expertise in the field of drug level 
measurements / therapeutic drug monitoring (TDM) and the application of pharmacokinetics 
/ pharmacodynamics (PK/PD), vascular surgeons, intensivists.
Selection of patients
- The selection of patients should take place daily, as to assess the urgency for the medical 
care needed. This selection can be carried out by all members of the Endocarditis Team. If 
necessary, members should be able to consult each other easily, for example in the daily 
heart team discussion.
- Discussion by the Endocarditis Team:
o Any patient with (a reasonable suspicion of) endocarditis, including patients 
with Staphylococcus aureus bacteremia, can be signed up for discussion in the 
Endocarditis Team. Even in patients with a ‘straight forward’ clinical picture, a 
517227-L-bw-gomes
Processed on: 19-4-2018 PDF page: 196
196
Chapter 10
discussion in the multidisciplinary team can have clear benefits. Therefore, it is 
advisable for referral centers to have a low threshold for signing up and discussing 
their patients in the regional Endocarditis Team, especially in the beginning after its 
setup, so that its procedures become well-known.
o For patients with uncomplicated endocarditis, regular consultation with the 
Endocarditis Team is recommended, with consultation and external visitation in the 
referral center if necessary (class IIa, level B). The intensity of this contact depends 
on the clinical condition of the patient and the available and required diagnostic 
and therapeutic expertise of the referring center.
- Transfer to the reference center:
o Complicated endocarditis: heart failure (hemodynamic instability or 
decompensation), abscess formation (or cavitation in other ways, e.g. mycotic 
aneurysm), neurological or otherwise embolic complications.
o Indication for surgical therapy: heart failure, uncontrolled infection, prevention of 
embolism. A distinction is made between emergency (within 24 hours), urgency 
(within 24-72 hours), and elective surgery. In the discussion whether or not to 
perform a surgical procedure (and when), the cardiothoracic surgeon’s judgment is 
important but evaluating a patient’s operability by the cardiologist and intensivist 
is also crucial.
o (Suspicion of) prosthetic valve endocarditis, because these patients are at high 
risk for complications (including valve dehiscence) and often require additional 
diagnostics (with advanced scanners), complicated antibiotic treatment and 
possibly an (acute) reoperation (with high mortality rates).
o Consider, in case of (suspicion of) device or lead infections, recurrent endocarditis, 
congenital heart disease or extensive comorbidity that can complicate treatment 
or further diagnostics.
Meetings by the Endocarditis Team
- Purpose: to provide recommendations on referral, additional diagnostics, surgery, 
antimicrobial therapy (drug, dosage and dosing schedule, duration), and follow-up.
- Frequency: we believe that the Endocarditis Team should preferably meet at regular intervals 
and at least once a week, depending on the number of patients signed up. However, in the 
first phase after the implementation of the team, meetings on an ad hoc basis may be more 
appropriate, depending on the number of signed up patients.
- Organization: meetings can be structured based on a predefined protocol (see Figure 1).
- Coordination: it is important that one central person (e.g. a PhD student, resident, or medical 
specialist, with a pre-defined back-up person if needed) is responsible for the preparation of 
a meeting, possibly carried out by a secretariat. This coordinator of the team should organize 
the whole meeting.
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Organisation of care:
§ Referral and return
§ Consultation













(CTA, PET, MRI, etc.)
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PCR
...to identify:





§ Course of disease
§ Antimicrobial therapy
§ Laboratory tests
§ Echocardiography (TTE, TEE)
§ All culture results (incl. 
susceptibility analysis)
§ Additional imaging
§ Portal of entry results
§ Medical question and/or 
proposal diagnostic/therapy
§ Brand, type
§ Date of implantation
§ Surgery report
§ Previous imaging after 
implantation




Heart failure, abscess 
formation, embolic or 
neurological complications





Feedback about diagnostic and therapeutic advice to referring physician (by telefone and writing)
Figure 1: Structure and procedures of the Endocarditis Team. Discussions should be structured based on a pre-established protocol.
Note: advice on the antimicrobial treatment concerns the choice of the right agents, dose and dosing schedule, the duration and 
follow up (measurement of blood levels/TDM and resulting adjustments) and PK/PD assessment based on MIC determination to 
ensure optimal effectiveness and minimal toxicity.
* Additional specialisms, present on indication.
- Registration: patients can be signed up via a standardized registration form (input). Clear 
requirements should be defined about the minimum patient data needed for discussion in 
the Endocarditis Team.
- Recommendation: a meeting by the Endocarditis Team should result in a joint recommendation 
concerning diagnostics, therapy and follow-up for the patient discussed (output). Reporting 
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of this recommendation ideally takes place by a letter or in the electronic patient file.
- Follow-up: during clinical admission and at the outpatient clinic after hospital discharge, 
with an individualized and clinically controlled frequency (ideally 1, 3, 6, and 12 months). 
Imaging is planned if indicated, for example in case of prosthetic valve endocarditis after the 
antimicrobial therapy or after heart valve surgery to obtain a baseline of the new anatomical 
situation.
Practical tips for setting up an Endocarditis Team.
1. Where to start?
If your center can act as a referral center, we recommend: 1) to develop an endocarditis protocol / 
guideline for your own referral center to communicate your workup and addresses for consultation. 
This can subsequently be shared with referring centers in the region; 2) to develop a joint scan protocol 
for diagnostic CT imaging of the heart and FDG-PET/CT imaging of the whole body after proper patient 
preparation, facilitating adequate imaging by means of a “one-stop shopping” principle.
Next, it is useful for setting up of an Endocarditis Team to appoint two dedicated endocarditis experts 
per medical specialty as members of the core team. Of such a couple, at least one should be present 
during team meetings and the other should be available as back-up.
 
If the Endocarditis Team has been set up, we would recommend to inform the medical specialists 
involved (including cardiologists, cardiothoracic surgeons, internist/ID specialist, medical microbiologist) 
in the possible referral centers in the region, to explain the role and purpose of your team.
2. Find a moment for regular meetings
It is recommended to build further on logistics already present. The regular heart team meetings 
(present: cardiologist, cardiothoracic surgeon), which will be present daily in most reference centers, 
seems the to be the most appropriate moment to exploit for this purpose. As next step, it is important 
to invite an internist/ID specialist, medical-microbiologist, radiologist, and nuclear medicine physician 
to this meeting. In January 2016, a start was made with the setting up of an Endocarditis Team at 
the Erasmus Medical Center (EMC). It proved to be relatively easy to additionally invite the medical 
microbiologist, internist/ID specialist, radiologist and nuclear medicine physician to discuss patients 
with (suspected) endocarditis in the heart team meetings. It was only six months later that the 
Endocarditis Team meetings were permanently scheduled on a regular basis, on average resulting in 
2-3 patients to discuss each week. At this time, the number of patients signed up from the region had 
increased as a result of a lower perceived threshold for consultation within the region. Once again, 
existing logistics were used: every Tuesday and Thursday a multidisciplinary meeting was already 
scheduled in which a cardiologist, cardiothoracic surgeon and an internist/ID specialist or a medical-
microbiologist were present. By organizing the Endocarditis Team meetings directly after this already 
existent multidisciplinary meeting, only the imaging specialists needed to be additionally invited.
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As a back-up, we would recommend to agree on how to meet on an ad-hoc basis in the Endocarditis 
Team in case patients are to be discussed but cannot wait until the next regular meeting. At the EMC, 
cardiologists and cardiothoracic surgeons have agreed that the physicians who consult the intensive 
care that day will join the meeting. In addition, the medical microbiologists and internists/ID specialists 
agreed that the consulting medical microbiologist or internist/ID specialist of that day will also join.
3. Where can patients be registered for discussion in the Endocarditis Team?
We recommend that patients are registered for discussion in the Endocarditis Team via an already 
involved secretary, for example the secretary of the Department of Thoracic Surgery (where patients 
are also registered for discussion in the regular heart team). Thereafter, this secretary can inform the 
Endocarditis Team via a special e-mail address, from where the coordinator can actively invite the other 
team members to a meeting. With this invitation, all relevant data from the patients to be discussed 
during the meeting, including referral letters, can be attached, so that all attending members can 
prepare themselves and additional data can be tracked down if needed (for example the antibiogram 
and MIC values for antibiotics  of a pathogen cultured in another center).
A joint e-mail address was created in the EMC to which all members of the Endocarditis Team have 
access. Via this joint e-mail address internal consultation can take place about questions from referring 
physicians and a joint answer can be formulated. 
It is important to clearly communicate the logistics concerning the registration of patients and the 
feedback from the discussed patients during the meeting to the referring physicians, for example in a 
newsletter. A short pocket manual or a website are also convenient means for this purpose.
4. Which data should at a minimum be provided during patient registration?
Concerning minimally requested diagnostic data, referring physicians should in our opinion at least 
provide a good echocardiography (images, not only the reports, and preferably also TEE) for their 
patients to be discussed in an Endocarditis Team meeting. In addition, the results of all blood cultures 
should be provided, including information regarding the use of antimicrobials at the time of blood 
culture collection, incubation duration,12 susceptibility spectrum and MIC values if applicable and/or 
targeted microbiological tests (PCR, serology). Discussing patients without the results of these tests is 
generally not useful, unless emergency complications occur. Information is also required with regard to:
• the medical history;
• the clinical course so far with a description of the current clinical condition of the patient;
• all treatments previously started and all previously given antibiotic agents (duration, dosing and 
dosing frequency);
• laboratory test results (in particular CRP, leucocyte number, kidney and liver function, levels of 
antibiotic agents in the blood);
• information about any intracardiac prosthetic material, if applicable (prosthetic valves, vascular 
prostheses, devices, etc.), including implant date and operation report (for example, about 
517227-L-bw-gomes
Processed on: 19-4-2018 PDF page: 200
200
Chapter 10
whether BioGlue is used);
• results of already performed additional imaging (CT, PET, MRI), as well as earlier (control) imaging of 
the thorax after any prosthetic valve implantation that can serve as a baseline and for comparison;
• already performed diagnostics to identify the portal of entry (e.g. consultation of the dental 
surgeon, colonoscopy).
A clear description of all required data from referring centers is crucial and prevents unnecessary 
work for the expertise center. A short pocket manual can help, but all requested data should also be 
mentioned on the patient registration form.
5. What to do with acute patients?
Analogous to acute patients with severe valve failure who are not discussed in the regular heart team 
before they are referred, acute referral to the surgical center should also be pursued for acute patients 
with (suspected) endocarditis and serious complications. Serious complications include severe valve 
leakage, (partial) dehiscence of a valve prosthesis, or multiple septic emboli caused by large vegetations. 
Acute referral of these patients usually takes place via the cardiologist or thoracic surgeon on duty. 
Even after emergency surgery, we would advise to subsequently discuss the patient in the Endocarditis 
Team, in order to set indications for additional diagnostics to identify the portal of entry or extracardiac 
infectious foci possibly present, and to formalize further antibiotic treatment and follow-up.
6. Feedback (to referring physicians)
It is advisable to send a report to the referring physician of each patient discussed during the meeting 
(also for patients from the referral center itself). Relevant items to report on include the clinical course 
from the patient, the laboratory and culture results, a chronological overview of all administered 
antibiotics, results of echocardiography and additional imaging, and a summary of the discussion in the 
Endocarditis Team with a conclusion and proposal of a diagnostic and therapeutic management plan. It 
may also be valuable to collect these letters for scientific, educational and quality purposes.
The referring physician can additionally be informed about the proposed management plan concerning 
further diagnostics or therapy by telephone. This is especially important if this physician refers patients 
from another center for discussion in the Endocarditis Team, or could not attend the meeting. In 
addition, the EMC experienced it to be useful to directly call the medical microbiologist and/or the 
internist/ID specialist of the referring center (by the medical microbiologist or internist/ID specialist of 
the reference center), certainly if the Endocarditis Team advises another antimicrobial regimen.
Feedback in the other direction, informing all those involved in the care of the discussed patient about 
his/her further clinical course, is also relevant. This enables the members of the Endocarditis Team to 
learn by experience, too.
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7. Coordination and organization
The Endocarditis Team meeting can be chaired by a medical specialist, resident or doctoral candidate, 
preferably the coordinator. It is important that the chairman fulfils a bridging function between all 
members of the Endocarditis Team and secures a broadly supported plan for management. For 
patients from the referral center, the treating physician of each patient should present the case during 
the meeting. For external patients whose referring physicians cannot attend the meeting, a medical 
specialist or resident from the referral center will need to get acquainted with the patient’s clinical data, 
track down any missing data, and present this patient during the meeting of the Endocarditis Team. A 
doctoral candidate with a medical background and some clinical experience in cardiology and infectious 
diseases could fulfil this function, too. It is recommended that the person who presents the patient 
during the meeting, also is responsible for reporting.
Optimize the clinical care for your endocarditis patients, through multidisciplinary discussing its clinical 
course in a critical and cooperative Endocarditis Team within the reference center in your area!
Figure 2a: Presentation of a case study to illustrate how the Endocarditis Team can be of added value.
A 32-year-old man was referred from a peripheral hospital for discussion in the Endocarditis Team. He was admitted 
due to a fever of 39.5 °C and chills for several days. His medical history comprises correction of a Tetralogy of Fallot 
with implantation of a ventricular septum defect (VSD) patch in 1986 and a pulmonary homograft in 2000. No typical 
clinical signs for endocarditis were present during physical examination. Blood cultures were positive for Streptococcus 
oralis (4/4 vials, MIC for penicillin 0.125 mg/L), already one day after admission. Intravenous benzyl-penicillin was 
started (12 grams/24 hours continuous infusion). TEE did not show any vegetations, but showed some thickening and 
a density on ultrasound of the intra-ventricular septum at the location of the VSD patch, referred to as calcification. 
The pulmonary homograft was not well assessable.
This case was discussed in the Endocarditis Team and the ultrasound images were re-evaluated. An indication to 
perform FDG-PET/CT was seen, in accordance with the ESC guideline5, because of the presence of a prosthetic 
pulmonary valve, the atypical findings during ultrasound examination, and the remaining uncertainty about a 
diagnosis of endocarditis with only positive blood cultures as major Duke criterion. Therefore, it was advised to 
perform a combined examination of FDG-PET with diagnostic CT angiography (CTA) at the outpatient clinic of the 
referral center. Additionally, it was advised to increase benzyl-penicillin (18 grams/24 hours continuous infusion) and 
to add gentamicin (3mg/kg, 1dd) to the antimicrobial therapy already started, as treatment of (possible) endocarditis.
FDG-PET/CTA showed a small sub-aortic cavity at the site of the VSD patch, which was new compared to previous 
CT-imaging of the heart, and which appeared strongly FDG-avid on the PET. Therefore, a small mycotic aneurysm 
was suspected. This finding was interpreted by the Endocarditis Team as consistent with infective endocarditis. As 
the patient responded well to the antibiotic therapy and there were no signs of shunting of blood or hemodynamic 
instability, it was decided to continue this conservative therapy and postpone surgery for the time being. It was 
advised to repeat a TTE and CTA after 6 weeks to reassess the mycotic aneurysm and evaluate the need for surgical 
correction.
 
By discussing this case in the Endocarditis Team both the diagnostic and therapeutic workups were adjusted. The 
patient was diagnosed with endocarditis (of prosthetic material, in this case a VSD patch) based on the information 
provided by additional imaging performed in the referral center and the antimicrobial treatment was adjusted 
accordingly.
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Figure 2b: Combined FDG-PET and diagnostic CTA-scan of the patient in the presented case. The transesophageal (A) and Doppler 
(B) view on the septum, with a clear calcified thickening at the site of the VSD-patch (asterisk), showed no evidence for a perforation 
of the septum (or left-right shunt). No vegetations or other signs of endocarditis were seen on the valves. However, the CTA (C, E) 
showed, cranially from the VSD-patch but still sub-aortal, a small opening in the intra-ventricular septum (arrow), which fills with 
contrast and was new compared to previous imaging after placement of the VSD-patch. The PET-scan (D, G) showed focal high-
intensive FDG-uptake at the location of this small opening in the intra-ventricular septum, indicating an infectious process (mycotic 
aneurysm), which is clearly visible on the fused PET / CTA images (F). This enabled us to diagnose this patients with endocarditis 
(from the VSD patch).
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